LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 277

Search options

  1. Article ; Online: Probiotics, gut microbiota and health.

    Butel, M-J

    Medecine et maladies infectieuses

    2014  Volume 44, Issue 1, Page(s) 1–8

    Abstract: ... studies on the best strain(s), dose, and algorithm of administration to be used are needed ...

    Abstract The human gut is a huge complex ecosystem where microbiota, nutrients, and host cells interact extensively, a process crucial for the gut homeostasis and host development with a real partnership. The various bacterial communities that make up the gut microbiota have many functions including metabolic, barrier effect, and trophic functions. Hence, any dysbiosis could have negative consequences in terms of health and many diseases have been associated to impairment of the gut microbiota. These close relationships between gut microbiota, health, and disease, have led to great interest in using probiotics (i.e. live micro-organisms), or prebiotics (i.e. non-digestible substrates) to positively modulate the gut microbiota to prevent or treat some diseases. This review focuses on probiotics, their mechanisms of action, safety, and major health benefits. Health benefits remain to be proven in some indications, and further studies on the best strain(s), dose, and algorithm of administration to be used are needed. Nevertheless, probiotic administration seems to have a great potential in terms of health that justifies more research.
    MeSH term(s) Adult ; Animals ; Clinical Trials as Topic ; Cultured Milk Products/microbiology ; Diabetes Mellitus, Type 2/microbiology ; Diabetes Mellitus, Type 2/therapy ; Diarrhea/microbiology ; Diarrhea/therapy ; Gastrointestinal Tract/immunology ; Gastrointestinal Tract/microbiology ; Gastrointestinal Tract/physiology ; Health Promotion ; Helicobacter Infections/therapy ; Humans ; Hypersensitivity/therapy ; Infant, Newborn ; Inflammatory Bowel Diseases/microbiology ; Inflammatory Bowel Diseases/therapy ; Irritable Bowel Syndrome/microbiology ; Irritable Bowel Syndrome/therapy ; Microbiota/drug effects ; Obesity/microbiology ; Obesity/therapy ; Probiotics/administration & dosage ; Probiotics/adverse effects ; Probiotics/pharmacology ; Probiotics/therapeutic use ; Species Specificity
    Language English
    Publishing date 2014-01
    Publishing country France
    Document type Journal Article ; Review
    ZDB-ID 423536-8
    ISSN 1769-6690 ; 0399-077X ; 1166-8237
    ISSN (online) 1769-6690
    ISSN 0399-077X ; 1166-8237
    DOI 10.1016/j.medmal.2013.10.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: The developing gut microbiota and its consequences for health.

    Butel, M-J / Waligora-Dupriet, A-J / Wydau-Dematteis, S

    Journal of developmental origins of health and disease

    2018  Volume 9, Issue 6, Page(s) 590–597

    Abstract: The developmental origin of health and disease highlights the importance of the period of the first 1000 days (from the conception to the 2 years of life). The process of the gut microbiota establishment is included in this time window. Various perinatal ...

    Abstract The developmental origin of health and disease highlights the importance of the period of the first 1000 days (from the conception to the 2 years of life). The process of the gut microbiota establishment is included in this time window. Various perinatal determinants, such as cesarean section delivery, type of feeding, antibiotics treatment, gestational age or environment, can affect the pattern of bacterial colonization and result in dysbiosis. The alteration of the early bacterial gut pattern can persist over several months and may have long-lasting functional effects with an impact on disease risk later in life. As for example, early gut dysbiosis has been involved in allergic diseases and obesity occurrence. Besides, while it was thought that the fetus developed under sterile conditions, recent data suggested the presence of a microbiota in utero, particularly in the placenta. Even if the origin of this microbiota and its eventual transfer to the infant are nowadays unknown, this placental microbiota could trigger immune responses in the fetus and would program the infant's immune development during fetal life, earlier than previously considered. Moreover, several studies demonstrated a link between the composition of placental microbiota and some pathological conditions of the pregnancy. All these data show the evidence of relationships between the neonatal gut establishment and future health outcomes. Hence, the use of pre- and/or probiotics to prevent or repair any early dysbiosis is increasingly attractive to avoid long-term health consequences.
    MeSH term(s) Anti-Bacterial Agents/adverse effects ; Cesarean Section/adverse effects ; Dysbiosis/drug therapy ; Dysbiosis/etiology ; Dysbiosis/microbiology ; Dysbiosis/prevention & control ; Female ; Gastrointestinal Microbiome/drug effects ; Gastrointestinal Microbiome/physiology ; Humans ; Immunity/physiology ; Infant ; Infant Nutritional Physiological Phenomena/physiology ; Infant, Newborn ; Intestines/growth & development ; Intestines/microbiology ; Maternal Exposure ; Placenta/microbiology ; Prebiotics/administration & dosage ; Pregnancy ; Pregnancy Complications/drug therapy ; Pregnancy Complications/microbiology ; Probiotics/administration & dosage
    Chemical Substances Anti-Bacterial Agents ; Prebiotics
    Language English
    Publishing date 2018-03-22
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2554780-X
    ISSN 2040-1752 ; 2040-1744
    ISSN (online) 2040-1752
    ISSN 2040-1744
    DOI 10.1017/S2040174418000119
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Food and Physical Activity Environment in the US-Affiliated Pacific Region: The Children's Healthy Living Program.

    Yamanaka, Ashley B / Strasburger, Sabine / Chow, Courtney / Butel, Jean / Wilkens, Lynne / Davis, James D / Deenik, Jonathan / Shallcross, Leslie / Novotny, Rachel

    Journal of nutrition education and behavior

    2022  Volume 55, Issue 2, Page(s) 96–104

    Abstract: Objective: To describe the quality of food and physical activity (PA) environments by World Bank Income level in jurisdictions from the Children's Healthy Living Program.: Design: Baseline cross-sectional community data were analyzed from 11 ... ...

    Abstract Objective: To describe the quality of food and physical activity (PA) environments by World Bank Income level in jurisdictions from the Children's Healthy Living Program.
    Design: Baseline cross-sectional community data were analyzed from 11 jurisdictions categorized by World Bank Income levels to describe exposure to different food and PA outlets. The Children's Healthy Living Program was a multilevel, multijurisdictional prevalence study and community intervention trial that reduced child obesity in the US-Affiliated Pacific region.
    Setting: US-Affiliated Pacific region.
    Participants: Food (n = 426) and PA (n = 552) Outlets.
    Main outcome measures: Physical activity and food scores that reflect the quality of the outlets that support being physically active and healthy eating options, respectively.
    Analysis: Descriptive statistics are presented as means ± SD or percentages.
    Results: High-income-income level jurisdictions had higher food and PA scores than middle-income level jurisdictions.
    Conclusions and implications: The US-Affiliated Pacific region has limited quality food and PA outlets in underserved communities at risk for obesity. The findings in this paper can be used to develop tools and design interventions to improve the food and PA environment to increase a healthier, active lifestyle.
    MeSH term(s) Child ; Humans ; Cross-Sectional Studies ; Food ; Pediatric Obesity/epidemiology ; Pediatric Obesity/prevention & control ; Exercise ; Diet, Healthy
    Language English
    Publishing date 2022-11-11
    Publishing country United States
    Document type Journal Article
    ISSN 1878-2620
    ISSN (online) 1878-2620
    DOI 10.1016/j.jneb.2022.08.009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Isolation and Characterization of Commensal Bifidobacteria Strains in Gut Microbiota of Neonates Born Preterm: A Prospective Longitudinal Study.

    Wydau-Dematteis, Sandra / Delannoy, Johanne / Téolis, Anne-Claire / Giuseppi, Agnès / Campeotto, Florence / Lapillonne, Alexandre / Butel, Marie-José / Aires, Julio

    Microorganisms

    2022  Volume 10, Issue 3

    Abstract: Bifidobacterial population dynamics were investigated using a longitudinal analysis of dominant species isolated from feces of neonates born preterm (singletons ( ...

    Abstract Bifidobacterial population dynamics were investigated using a longitudinal analysis of dominant species isolated from feces of neonates born preterm (singletons (
    Language English
    Publishing date 2022-03-18
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2720891-6
    ISSN 2076-2607
    ISSN 2076-2607
    DOI 10.3390/microorganisms10030654
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Congenital asplenia study: clinical and laboratory characterisation of adults with congenital asplenia.

    Butel-Simoes, Grace I / Jones, Penelope / Wood, Erica M / Spelman, Denis / Woolley, Ian J / Ojaimi, Samar

    Annals of hematology

    2022  Volume 101, Issue 7, Page(s) 1421–1434

    Abstract: Congenital asplenia is a rare disorder commonly associated with other visceral and cardiac congenital anomalies. Isolated congenital asplenia is even less common than syndromic forms. The risk of severe bacterial infections associated with asplenia is ... ...

    Abstract Congenital asplenia is a rare disorder commonly associated with other visceral and cardiac congenital anomalies. Isolated congenital asplenia is even less common than syndromic forms. The risk of severe bacterial infections associated with asplenia is the most concerning clinical implication and carries a significant mortality risk. Prophylactic measures against the clinical syndrome known as overwhelming postsplenectomy infections (OPSI) include vaccination, prophylactic and emergency antibiotics and health education including fever management and travel advice. This case series describes fourteen adults with congenital asplenia and polysplenia syndrome, most of whom were diagnosed incidentally as adults, and outlines the nature of their diagnosis, clinical phenotype, family history and key pathology findings.
    MeSH term(s) Anti-Bacterial Agents/therapeutic use ; Humans ; Splenic Diseases ; Syndrome ; Vaccination
    Chemical Substances Anti-Bacterial Agents
    Language English
    Publishing date 2022-04-22
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 1064950-5
    ISSN 1432-0584 ; 0939-5555 ; 0945-8077
    ISSN (online) 1432-0584
    ISSN 0939-5555 ; 0945-8077
    DOI 10.1007/s00277-022-04765-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Structural Features and Genetic Diversity in

    Godwe, Célestin / Vidal, Nicole / Muwonga, Jérémie / Butel, Christelle / Serrano, Laetitia / Edidi, Samuel / Ahuka-Mundeke, Steve / Koro Koro, Francioli / Etoa, Xavier / Tongo, Marcel / Peeters, Martine / Ayouba, Ahidjo

    AIDS research and human retroviruses

    2023  Volume 40, Issue 3, Page(s) 181–187

    Abstract: Type-1 HIV (HIV-1) group M (HIV-1M) genetic diversity is highest in the Congo Basin where the epidemic ignited a century ago. HIV-1M has diversified into multiple subtypes, sub-subtypes, and circulating and unique recombinant forms (CRFs/URFs). An ... ...

    Abstract Type-1 HIV (HIV-1) group M (HIV-1M) genetic diversity is highest in the Congo Basin where the epidemic ignited a century ago. HIV-1M has diversified into multiple subtypes, sub-subtypes, and circulating and unique recombinant forms (CRFs/URFs). An unanswered question is why some rare subtypes never reached epidemic levels despite their age. Several studies identified the role of HIV-1M accessory genes
    MeSH term(s) Humans ; Democratic Republic of the Congo/epidemiology ; Phylogeny ; HIV-1/genetics ; Genes, gag/genetics ; HIV Infections ; HIV Seropositivity ; Genetic Variation
    Language English
    Publishing date 2023-07-05
    Publishing country United States
    Document type Journal Article
    ZDB-ID 639130-8
    ISSN 1931-8405 ; 0889-2229
    ISSN (online) 1931-8405
    ISSN 0889-2229
    DOI 10.1089/AID.2022.0154
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Neonatal necrotizing enterocolitis:

    Ferraris, Laurent / Balvay, Aurélie / Bellet, Deborah / Delannoy, Johanne / Maudet, Claire / Larcher, Thibaut / Rozé, Jean-Christophe / Philippe, Catherine / Meylheuc, Thierry / Butel, Marie-José / Rabot, Sylvie / Aires, Julio

    Gut microbes

    2023  Volume 15, Issue 1, Page(s) 2172666

    Abstract: Bacterial colonization in the gut plays a pivotal role in neonatal necrotizing enterocolitis (NEC) development, but the relationship between bacteria and NEC remains unclear. In this study, we aimed to elucidate whether bacterial butyrate end- ... ...

    Abstract Bacterial colonization in the gut plays a pivotal role in neonatal necrotizing enterocolitis (NEC) development, but the relationship between bacteria and NEC remains unclear. In this study, we aimed to elucidate whether bacterial butyrate end-fermentation metabolites participate in the development of NEC lesions and confirm the enteropathogenicity of
    MeSH term(s) Infant, Newborn ; Humans ; Animals ; Clostridium butyricum/genetics ; Enterocolitis, Necrotizing/microbiology ; Fermentation ; Gastrointestinal Microbiome ; Butyrates ; Infant, Newborn, Diseases
    Chemical Substances Butyrates
    Language English
    Publishing date 2023-02-17
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2575755-6
    ISSN 1949-0984 ; 1949-0984
    ISSN (online) 1949-0984
    ISSN 1949-0984
    DOI 10.1080/19490976.2023.2172666
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Established and Emerging Cancer Therapies and Cardiovascular System: Focus on Hypertension-Mechanisms and Mitigation.

    Butel-Simoes, Lloyd E / Haw, Tatt Jhong / Williams, Trent / Sritharan, Shanathan / Gadre, Payal / Herrmann, Sandra M / Herrmann, Joerg / Ngo, Doan T M / Sverdlov, Aaron L

    Hypertension (Dallas, Tex. : 1979)

    2023  Volume 80, Issue 4, Page(s) 685–710

    Abstract: Cardiovascular disease and cancer are 2 of the leading causes of death worldwide. Although improvements in outcomes have been noted for both disease entities, the success of cancer therapies has come at the cost of at times very impactful adverse events ... ...

    Abstract Cardiovascular disease and cancer are 2 of the leading causes of death worldwide. Although improvements in outcomes have been noted for both disease entities, the success of cancer therapies has come at the cost of at times very impactful adverse events such as cardiovascular events. Hypertension has been noted as both, a side effect as well as a risk factor for the cardiotoxicity of cancer therapies. Some of these dynamics are in keeping with the role of hypertension as a cardiovascular risk factor not only for heart failure, but also for the development of coronary and cerebrovascular disease, and kidney disease and its association with a higher morbidity and mortality overall. Other aspects such as the molecular mechanisms underlying the amplification of acute and long-term cardiotoxicity risk of anthracyclines and increase in blood pressure with various cancer therapeutics remain to be elucidated. In this review, we cover the latest clinical data regarding the risk of hypertension across a spectrum of novel anticancer therapies as well as the underlying known or postulated pathophysiological mechanisms. Furthermore, we review the acute and long-term implications for the amplification of the development of cardiotoxicity with drugs not commonly associated with hypertension such as anthracyclines. An outline of management strategies, including pharmacological and lifestyle interventions as well as models of care aimed to facilitate early detection and more timely management of hypertension in patients with cancer and survivors concludes this review, which overall aims to improve both cardiovascular and cancer-specific outcomes.
    MeSH term(s) Humans ; Cardiotoxicity/etiology ; Cardiotoxicity/diagnosis ; Cardiotoxicity/drug therapy ; Early Detection of Cancer/adverse effects ; Cardiovascular System ; Cardiovascular Diseases/complications ; Hypertension/complications ; Neoplasms/complications ; Neoplasms/drug therapy ; Anthracyclines/adverse effects ; Antineoplastic Agents/adverse effects
    Chemical Substances Anthracyclines ; Antineoplastic Agents
    Language English
    Publishing date 2023-02-09
    Publishing country United States
    Document type Journal Article ; Review ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 423736-5
    ISSN 1524-4563 ; 0194-911X ; 0362-4323
    ISSN (online) 1524-4563
    ISSN 0194-911X ; 0362-4323
    DOI 10.1161/HYPERTENSIONAHA.122.17947
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Non-SARS-CoV-2 respiratory viral detection and whole genome sequencing from COVID-19 rapid antigen test devices: a laboratory evaluation study.

    Moso, Michael A / Taiaroa, George / Steinig, Eike / Zhanduisenov, Madiyar / Butel-Simoes, Grace / Savic, Ivana / Taouk, Mona L / Chea, Socheata / Moselen, Jean / O'Keefe, Jacinta / Prestedge, Jacqueline / Pollock, Georgina L / Khan, Mohammad / Soloczynskyj, Katherine / Fernando, Janath / Martin, Genevieve E / Caly, Leon / Barr, Ian G / Tran, Thomas /
    Druce, Julian / Lim, Chuan K / Williamson, Deborah A

    The Lancet. Microbe

    2024  Volume 5, Issue 4, Page(s) e317–e325

    Abstract: Background: There has been high uptake of rapid antigen test device use for point-of-care COVID-19 diagnosis. Individuals who are symptomatic but test negative on COVID-19 rapid antigen test devices might have a different respiratory viral infection. We ...

    Abstract Background: There has been high uptake of rapid antigen test device use for point-of-care COVID-19 diagnosis. Individuals who are symptomatic but test negative on COVID-19 rapid antigen test devices might have a different respiratory viral infection. We aimed to detect and sequence non-SARS-CoV-2 respiratory viruses from rapid antigen test devices, which could assist in the characterisation and surveillance of circulating respiratory viruses in the community.
    Methods: We applied archival clinical nose and throat swabs collected between Jan 1, 2015, and Dec 31, 2022, that previously tested positive for a common respiratory virus (adenovirus, influenza, metapneumovirus, parainfluenza, rhinovirus, respiratory syncytial virus [RSV], or seasonal coronavirus; 132 swabs and 140 viral targets) on PCR to two commercially available COVID-19 rapid antigen test devices, the Panbio COVID-19 Ag Rapid Test Device and Roche SARS-CoV-2 Antigen Self-Test. In addition, we collected 31 COVID-19 rapid antigen test devices used to test patients who were symptomatic at The Royal Melbourne Hospital emergency department in Melbourne, Australia. We extracted total nucleic acid from the device paper test strips and assessed viral recovery using multiplex real-time PCR (rtPCR) and capture-based whole genome sequencing. Sequence and genome data were analysed through custom computational pipelines, including subtyping.
    Findings: Of the 140 respiratory viral targets from archival samples, 89 (64%) and 88 (63%) were positive on rtPCR for the relevant taxa following extraction from Panbio or Roche rapid antigen test devices, respectively. Recovery was variable across taxa: we detected influenza A in nine of 18 samples from Panbio and seven of 18 from Roche devices; parainfluenza in 11 of 20 samples from Panbio and 12 of 20 from Roche devices; human metapneumovirus in 11 of 16 from Panbio and 14 of 16 from Roche devices; seasonal coronavirus in eight of 19 from Panbio and two of 19 from Roche devices; rhinovirus in 24 of 28 from Panbio and 27 of 28 from Roche devices; influenza B in four of 15 in both devices; and RSV in 16 of 18 in both devices. Of the 31 COVID-19 devices collected from The Royal Melbourne Hospital emergency department, 11 tested positive for a respiratory virus on rtPCR, including one device positive for influenza A virus, one positive for RSV, four positive for rhinovirus, and five positive for SARS-CoV-2. Sequences of target respiratory viruses from archival samples were detected in 55 (98·2%) of 56 samples from Panbio and 48 (85·7%) of 56 from Roche rapid antigen test devices. 98 (87·5%) of 112 viral genomes were completely assembled from these data, enabling subtyping for RSV and influenza viruses. All 11 samples collected from the emergency department had viral sequences detected, with near-complete genomes assembled for influenza A and RSV.
    Interpretation: Non-SARS-CoV-2 respiratory viruses can be detected and sequenced from COVID-19 rapid antigen devices. Recovery of near full-length viral sequences from these devices provides a valuable opportunity to expand genomic surveillance programmes for public health monitoring of circulating respiratory viruses.
    Funding: Australian Government Medical Research Future Fund and Australian National Health and Medical Research Council.
    MeSH term(s) Humans ; COVID-19/diagnosis ; SARS-CoV-2/genetics ; Influenza, Human/diagnosis ; COVID-19 Testing ; Australia ; Metapneumovirus/genetics ; Paramyxoviridae Infections ; Respiratory Syncytial Virus, Human/genetics ; Whole Genome Sequencing
    Language English
    Publishing date 2024-02-12
    Publishing country England
    Document type Journal Article
    ISSN 2666-5247
    ISSN (online) 2666-5247
    DOI 10.1016/S2666-5247(23)00375-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Gut Microbiota Diversity of Preterm Neonates Is Associated With

    Couturier, Jeanne / Lepage, Patricia / Jolivet, Sarah / Delannoy, Johanne / Mesa, Victoria / Ancel, Pierre-Yves / Rozé, Jean-Christophe / Butel, Marie-José / Barbut, Frédéric / Aires, Julio

    Frontiers in cellular and infection microbiology

    2022  Volume 12, Page(s) 907323

    Abstract: In adults, ...

    Abstract In adults,
    MeSH term(s) Adult ; Child ; Clostridioides ; Clostridioides difficile/genetics ; Clostridium Infections/microbiology ; Feces/microbiology ; Gastrointestinal Microbiome/genetics ; Humans ; Infant, Newborn ; RNA, Ribosomal, 16S/genetics
    Chemical Substances RNA, Ribosomal, 16S
    Language English
    Publishing date 2022-07-06
    Publishing country Switzerland
    Document type Journal Article ; Multicenter Study ; Research Support, Non-U.S. Gov't
    ZDB-ID 2619676-1
    ISSN 2235-2988 ; 2235-2988
    ISSN (online) 2235-2988
    ISSN 2235-2988
    DOI 10.3389/fcimb.2022.907323
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top